PT  - JOURNAL ARTICLE
AU  - Ekawati, Lenny L.
AU  - Arif, Ahmad
AU  - Hidayana, Irma
AU  - Nurhasim, Ahmad
AU  - Munziri, M. Zakiyuddin
AU  - Lestari, Karina D.
AU  - Tan, Amanda
AU  - Ferdiansyah, Firdaus
AU  - Nashiruddin, Fikry
AU  - Adnani, Qorinah E.S.
AU  - Malik, Halik
AU  - Maharani, Tri
AU  - Riza, Andy
AU  - Pasaribu, Monalisa
AU  - Abidin, Khairul
AU  - Andrianto, Adhi A.
AU  - Nursalam,
AU  - Sri Suhardiningsih, A.V.
AU  - Jubaedah, Ade
AU  - Widodo, N.S.
AU  - Surendra, Henry
AU  - Sudoyo, Herawati
AU  - Smith, Adrian D.
AU  - Kreager, Philip
AU  - Baird, J. Kevin
AU  - Elyazar, Iqbal R.F.
TI  - Mortality among healthcare workers in Indonesia during 18 months of COVID-19
AID  - 10.1101/2022.04.27.22274334
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.27.22274334
4099  - http://medrxiv.org/content/early/2022/04/28/2022.04.27.22274334.short
4100  - http://medrxiv.org/content/early/2022/04/28/2022.04.27.22274334.full
AB  - The impact of SARS-CoV-2 infections upon Indonesian health care workers (HCWs) remains unclear, as mortality data specific to HCWs is not systematically collected or analyzed in this setting. This report describes findings from a systematic collation, abstraction and analysis of HCW fatalities during the first 18 months of COVID-19 in Indonesia. HCW who died during the period of March 2020 to July 2021 across Indonesia were identified on Pusara Digital, a community web-based digital cemetery database dedicated to HCW. We calculated mortality rates and death risk ratio among HCWs and the general population. Qualitative methods explored concerns regarding mortality among HCWs. The analysis suggests that at least 1,545 HCWs died during the study period. The death of males and females HCWs were almost equally distributed (51% vs. 49%). Most were medical doctors and specialists (535, 35%), nurses (428, 28%), and midwives (359, 23%). Deaths most frequently occurred in the age group of 40 to 59 years old with the median age of 50 years (IQR: 39-59). At least 322 (21%) deaths occurred with pre-existing conditions, including 45 who were pregnant. We estimated a minimal HCW mortality rate in Indonesia at 1.707 deaths per 1000 HCW during the first 18 months of COVID-19. Provincial HCW mortality rates ranged from 0.136 (West Sulawesi) to 5.32 HCW deaths per 1000 HCWs (East Java). HCW had a significantly higher mortality rate than the general population (RR = 4.92, 95% CI 4.67 – 5.17). The COVID-19 event in Indonesia resulted in the loss of many hundreds of HCWs, most of them being senior physicians, nurses, and midwives. The HCW death rates is 5-times higher than everyone else. The sheer sparseness of the workforce requires more protective steps and a national systematic surveillance of occupational mortality is urgently needed in this setting.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPusara Digital, the main source of this study, was partially funded by the Digital Access Program of the British Embassy in Indonesia and as part of collaborative work with the Association of Indonesian Medical Doctors (Ikatan Dokter Indonesia; IDI), National Association of Nurses (Persatuan Perawat Nasional Indonesia, PPNI), Association of Midwives (Ikatan Bidan Indonesia, IBI), Association of Medical Laboratory Technologists (Persatuan Ahli Teknologi Laboratorium Kesehatan Indonesia, PATELKI), The Conversation, and Eijkman-Oxford Clinical Research Unit (EOCRU).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Health Research Ethics Committee of the National Institute of Health Research and Development, Ministry of Health, Republic of Indonesia (LB.02.01/2/KE/620/2020).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors All data produced in the present work are contained in the manuscript All data produced are available online at Pusara Digital; https://nakes.laporcovid19.org/ and the Ministry of Health in the Republic of Indonesia. https://infeksiemergingkemkesgoid/dashboard/covid-19. 2022.